US pharmaceutical major Pfizer reinforced its position as the
world's largest drug company in 2002 after putting in sales of
$29.45 billion (€25.12 bn) in 2002, a hike of 11 per cent over the
prior year, according to a new analysis...
BioForce Nanosciences of the USA has been granted a US patent
covering nanoscale arrays useful in identifying target materials or
for characterising molecular interaction events.
The German state of Saxony has implemented a $230 million,
five-year investment programme in a bid to nurture the development
of 'biosaxony,' centring on the establishment of regional
biotechnology hot spots in Leipzig and...
Baxter Healthcare and GlycoFi have entered into a two-year research
collaboration under which Baxter will evaluate the potential of
using the latter firm's fungal expression platform for the
production of human therapeutic proteins....
Belgian pharmaceutical and chemicals firm Solvay expects to launch
a new version of its Influvac brand flu vaccine, based on a novel
cell-based production process, in 2005. The speed of the new
process means that a vaccine can be...
Sweden's Amarin Development has been commissioned by GEA
Farmaceutisk Fabrik, a Danish subsidiary of German pharmaceutical
company HEXAL, to develop a formulation of one of its candidate
compounds.
Aventis has licensed in a new system from US firm SciQuest aimed at
enhancing the management of biological sample inventories at its
process development facilities in Frankfurt, Germany and
Vitry-sur-Seine in France. If this initial...
Drug delivery company Atrix Laboratories confirmed this week that
the German regulatory authority, Bundesinstitut fur Arzneimittel
und Medizinprodukte (BfArM), had recently completed a successful
inspection of Atrix's manufacturing...
BASF AG's Fine Chemicals division is expanding production of
pharmaceutical active ingredients with the construction of a new
plant at its site in Minden, Germany. A spokesman for the company
told In-pharmatechnologist.com that...
New bulk drug manufacturing facilities, worth a total of around
€123 million (£90 million), were officially opened this week at
AstraZeneca's Avlon Works near Bristol in the UK.
As this edition of In-pharmatechnologist.com goes online, the US
Food and Drug Administration is convening the inaugural meeting of
its Advisory Committee for Pharmaceutical Science's Manufacturing
Subcommittee.
"Tremendous advances in science and technology, along with the
shrinking period for patent exclusivity, are creating unprecedented
opportunities for the drug development industry," said a CEO
this week while discussing the...
An international conference serving global centres of excellence
for biotechnology, so-called 'bio-technopoles,' life science parks
and 'bio-incubators' will take place ahead of the 7th European
Biotech Crossroads...
BASF Plant Science, the plant biotechnology subsidiary of chemical
giant BASF, has entered into an agreement with Cellectis,
specialists in genome engineering and a recent spin-off from the
Institut Pasteur, that will provide BASF...
Swiss life science company Lonza, that earlier this week announced
imminent cutbacks and job losses, has settled a patent infringement
action with Nutrition 21, a US company that currently holds 22
patents for chromium compounds.
